Mizuho Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$59K Hold
521
0.01% 602
2016
Q2
$65K Buy
521
+204
+64% +$24.6K 0.01% 630
2016
Q1
$33K Sell
317
-204
-39% -$21.2K 0.01% 606
2015
Q4
$57K Hold
521
0.01% 634
2015
Q3
$52K Buy
521
+204
+64% +$22.2K 0.01% 610
2015
Q2
$36K Hold
317
0.01% 649
2015
Q1
$33K Buy
317
+196
+162% +$20.9K 0.01% 606
2014
Q4
$15K Hold
121
﹤0.01% 647
2014
Q3
$18K Hold
121
﹤0.01% 615
2014
Q2
$20K Hold
121
﹤0.01% 569
2014
Q1
$24K Hold
121
﹤0.01% 465
2013
Q4
$23K Hold
121
﹤0.01% 455
2013
Q3
$20K Hold
121
﹤0.01% 507
2013
Q2
$18K Buy
+121
New +$17.1K ﹤0.01% 499

Other funds holding CLB

Mizuho Asset Management's CLB Position: Q3 2016 in Review

Mizuho Asset Management held its Core Laboratories (CLB) position steady in Q3 2016 at 521 shares worth $59K. The position accounts for 0.01% of the portfolio, ranked #602.

Mizuho Asset Management first reported a position in CLB in Q2 2013 and has held it in 14 quarters since. The position peaked at $65K in Q2 2016. 373 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

  • Mizuho Asset Management held 521 shares of Core Laboratories worth $59K as of Q3 2016.
  • Mizuho Asset Management left its Core Laboratories share count unchanged in Q3 2016.
  • Core Laboratories made up 0.01% of Mizuho Asset Management's portfolio in Q3 2016, its #602 holding.
  • Mizuho Asset Management first reported a position in Core Laboratories in Q2 2013 and has held it in 14 quarters since.
  • Mizuho Asset Management's Core Laboratories position peaked at $65K in Q2 2016.
  • 373 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.